He, Xiaoning - 天津大学 - 药物科学与技术学院

个人简介

Education Experience： 2014-2017 Ph. D. Health and Pharmacy Administration Tianjin University 2012-2014 Master of Management Health and Pharmacy Administration Tianjin University 2008-2012 Bachelor of Engineering Pharmaceutical Engineering Fuzhou University

研究领域

1. Health care big data analyses based on insurance claims data 2. Cost-effectiveness analysis and comparative effectiveness and outcomes research 3. Health-related quality of life and health utility measurement 4. Systematic review of clinical studies and economic evaluations

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Diversity when interpreting evidence in network meta-analyses (NMAs) on similar topics: an example case of NMAs on diabetic macular oedema Jing Wu, Clive Adams, Xiaoning He, Fang Qi & Jun Xia Systematic Reviews volume 12, Article number: 189 (2023) China Health Related Outcomes Measures (CHROME): development of a descriptive system to support cardiovascular disease specific preference-based measure for the Chinese population Li Xue,Zhao Kun,Li Kexin,Wang Wenjun,Feng Siting,Wu Jing,He Xiaoning,Xie Shitong,Hu Hao,Fan Jing,Fu Qiang,Xie Feng Page:2463-2476 ISSN:0962-9343 2023 Container-title:Quality of Life Research Incorporating absolute effects to enrich interpretation of findings from meta-analyses Jing Wu，Shitong Xie，Xiaoning He，Tianqi Hong，Liang Yao Published:September, 2023DOI:https://doi.org/10.1016/S1470-2045(23)00384-4 Correction: The Study on Cervical Cancer Burden in 127 Countries and Its Socioeconomic Influence Factors Xu Tingting,Yang Xueling,He Xiaoning,Wu Jing Page:162-162 ISSN:2210-6014 2023 Container-title:Journal of Epidemiology and Global Health The Study on Cervical Cancer Burden in 127 Countries and Its Socioeconomic Influence Factors Xu Tingting,Yang Xueling,He Xiaoning,Wu Jing Journal of Epidemiology and Global Health (2023) 13:154–161 https://doi.org/10.1007/s44197-022-00081-1 Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting Dong Xinyue,He Xiaoning,Wu Jing Page:1187-1205 ISSN:1170-7690 2022 Container-title:PharmacoEconomics A guideline for economic evaluations of vaccines and immunization programs in China Hai Fang, Chen Chen, Yu Fang, Xiaoning He, Zhiyuan Hou, Minghuan Jiang, Yawen Jiang, Shunping Li, Yang Liu, Binyan Sui, Qiang Sun, Jing Wu, Tingting Xu, Juan Yang, Zundong Yin, Xiaohua Ying, Beibei Yuan, Hui Zheng & Yaming Zheng HUMAN VACCINES & IMMUNOTHERAPEUTICS 2022, VOL. 18, NO. 6, e2132802 (9 pages) https://doi.org/10.1080/21645515.2022.2132802 Can case-based payment contain healthcare costs? - A curious case from China Social Science & Medicine 2022-11 | Journal article DOI: 10.1016/j.socscimed.2022.115384 CONTRIBUTORS: Jing Wu; Xiaoning He; Xing Lin Feng China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population Wu Jing,He Xiaoning,Chen Pinan,Xie Shitong,Li Xue,Hu Hao,Zhao Kun,Xie Feng PharmacoEconomics (2022) 40:957–969 https://doi.org/10.1007/s40273-022-01151-9 How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China Zhang Mengqian,He Xiaoning,Wu Jing,Wang Xinyue,Jiang Qian,Xie Feng Page:1768-1777 ISSN:1098-3015 2022 Container-title:Value in Health Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov Model Applied Health Economics and Health Policy 2022 | Journal article DOI: 10.1007/s40258-022-00732-1 EID: 2-s2.0-85128941846 Part of ISSN: 11791896 11755652 CONTRIBUTORS: Liu, J.; He, X.; Wu, J. Policy Updates on Access to and Affordability of Innovative Medicines in China Value in Health Regional Issues 2022 | Journal article DOI: 10.1016/j.vhri.2021.12.003 EID: 2-s2.0-85125259007 Part of ISSN: 22121102 22121099 CONTRIBUTORS: Liu, G.G.; Wu, J.; He, X.; Jiang, Y. The Impact of Hyperkalemia on Mortality and Healthcare Resource Utilization Among Patients With Chronic Kidney Disease: A Matched Cohort Study in China Frontiers in Public Health 2022 | Journal article DOI: 10.3389/fpubh.2022.855395 EID: 2-s2.0-85127937953 Part of ISSN: 22962565 CONTRIBUTORS: Zhang, J.; He, X.; Wu, J. Differences in lung cancer treatment preferences among oncologists, patients and family members: A semi-structured qualitative study in China Patient Preference and Adherence 2021 | Journal article DOI: 10.2147/PPA.S299399 EID: 2-s2.0-85104940203 Part of ISSN: 1177889X CONTRIBUTORS: He, X.; Zhang, M.; Wu, J.; Xu, S.; Jiang, X.; Wang, Z.; Zhang, S.; Xie, F. Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China Diabetes Therapy 2021 | Journal article DOI: 10.1007/s13300-020-00967-y EID: 2-s2.0-85096239385 Part of ISSN: 18696961 18696953 CONTRIBUTORS: He, X.; Zhang, Y.; Zhou, Y.; Dong, C.; Wu, J. Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study PharmacoEconomics - Open 2021 | Journal article DOI: 10.1007/s41669-020-00212-z EID: 2-s2.0-85098779579 Part of ISSN: 25094254 25094262 CONTRIBUTORS: Yang, F.; Jiang, S.; He, X.-N.; Li, H.-C.; Wu, H.-Y.; Zhang, T.-T.; Wu, J. Eliciting SF-6Dv2 health state utilities using an anchored best-worst scaling technique Social Science and Medicine 2021 | Journal article DOI: 10.1016/j.socscimed.2021.114018 EID: 2-s2.0-85105747525 Part of ISSN: 18735347 02779536 CONTRIBUTORS: Osman, A.M.Y.; Wu, J.; He, X.; Chen, G. Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension PharmacoEconomics 2021 | Journal article DOI: 10.1007/s40273-020-00997-1 EID: 2-s2.0-85101071092 Part of ISSN: 11792027 11707690 CONTRIBUTORS: Wu, J.; Xie, S.; He, X.; Chen, G.; Bai, G.; Feng, D.; Hu, M.; Jiang, J.; Wang, X.; Wu, H. et al. Adherence to statins and its impact on clinical outcomes: A retrospective population-based study in China BMC Cardiovascular Disorders 2020 | Journal article DOI: 10.1186/s12872-020-01566-2 EID: 2-s2.0-85086356364 Part of ISSN: 14712261 CONTRIBUTORS: Zhao, B.; He, X.; Wu, J.; Yan, S. Association of severe hypoglycemia with all-cause mortality and complication risks among patients with type 2 diabetes mellitus in China Diabetes Research and Clinical Practice 2020 | Journal article DOI: 10.1016/j.diabres.2020.108493 EID: 2-s2.0-85094894146 Part of ISSN: 18728227 01688227 CONTRIBUTORS: Zhang, J.; He, X.; Zhang, L.; Wang, K.; Chen, H.; Wu, J. Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China Value in Health 2020 | Journal article DOI: 10.1016/j.jval.2020.06.010 EID: 2-s2.0-85090300355 Part of ISSN: 15244733 10983015 CONTRIBUTORS: Xie, S.; Wu, J.; He, X.; Chen, G.; Brazier, J.E. The Simplified Chinese version of SF-6Dv2: translation, cross-cultural adaptation and preliminary psychometric testing Quality of Life Research 2020 | Journal article DOI: 10.1007/s11136-020-02419-3 EID: 2-s2.0-85078602438 Part of ISSN: 15732649 09629343 CONTRIBUTORS: Wu, J.; Xie, S.; He, X.; Chen, G.; Brazier, J.E. Economic evaluation of novel direct-acting antivirals in the treatment of chronic hepatitis c virus genotype 1b in china based on markov model,基于Markov模型对新型抗病毒药物治疗基因1b型慢性丙型肝炎的药物经济学评价 Chinese Pharmaceutical Journal 2019 | Journal article DOI: 10.11669/cpj.2019.15.016 EID: 2-s2.0-85074643607 Part of ISSN: 10012494 CONTRIBUTORS: Yang, F.-N.; He, X.-N.; Wu, J. Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China Clinical Therapeutics 2019 | Journal article DOI: 10.1016/j.clinthera.2019.01.005 EID: 2-s2.0-85061403992 Part of ISSN: 1879114X 01492918 CONTRIBUTORS: He, X.; Wang, Y.; Cong, H.; Lu, C.; Wu, J. Initiation and persistence with antiplatelet agents among the patients with acute coronary syndromes: A retrospective, observational database study in China Patient Preference and Adherence 2019 | Journal article DOI: 10.2147/PPA.S228065 EID: 2-s2.0-85077009793 Part of ISSN: 1177889X CONTRIBUTORS: Liu, X.; He, X.; Wu, J.; Luo, D.